VIMTA LABS
|
The Current P/E Ratio of VIMTA LABS is 44.82.
| Share Price | ₹594.6 | Dec 11,2025 |
| Market Cap | ₹2,651.9 Cr | |
| Earnings-TTM | ₹59.2 Cr | TTM-Consolidated Results |
| Price/Earnings | 44.82x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of VIMTA LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,651.9 Cr] as on Dec 11,2025
(/) Earnings [ ₹59.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 44.82x ]
Thus, for VIMTA LABS , the investors are currently willing to pay 44.82 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VIMTA LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VIMTA LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of VIMTA LABS
PE Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.22x.
- VIMTA LABS 's operated at median p/e ratio of 16.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 24.04x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2023 of 14.44x.
How does VIMTA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| VIMTA LABS | 59.16 | 44.82 | 2,651.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 41.22 | 433,536.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.71 | 170,753.0 |
| CIPLA LTD | 5,453.86 | 22.40 | 122,143.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.12 | 128,650.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.57 | 106,244.0 |
| MANKIND PHARMA LTD | 1,767.06 | 50.62 | 89,442.5 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.66 | 92,820.0 |
| LUPIN LTD | 4,347.53 | 21.86 | 95,030.1 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.75 | 68,099.0 |
| ABBOTT INDIA LTD | 1,508.95 | 39.75 | 59,982.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VIMTA LABS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.57x |
| Max industry PE | 68.71x |
| Median industry PE | 39.75x |
| Average industry PE | 36.95x |
You may also like the below Video Courses